North Star CBD

Scientific Content Provided by Mile High Labs (USA)
Officially Presented by North Star CBD – Exclusive Regional Distributor

At North Star CBD, we provide access to high-quality cannabinoid ingredients supported by extensive scientific research. Below is a comprehensive scientific overview of cannabinoids based on validated data from our manufacturing partner.

Insights and Updates

Legal Notice:All blog content, including text, images, and materials displayed on this website, is the exclusive intellectual property of Mile High Labs.North Star CBD displays this content solely in its capacity as a regional sales and distribution representative for designated territories. This content is used strictly for informational and commercial support purposes.North Star CBD does not claim any ownership, authorship, copyright, or intellectual property rights over this content. All rights remain exclusively with Mile High Labs.This content is used with acknowledgment of Mile High Labs as the original source.

CBD Is Entering a Regulated Era — Why Federal Rescheduling Changes the Landscape

For years, CBD has existed in an uncomfortable contradictionLegal, but constrainedCommercially visible, but institutionally avoidedWidely used, but rarely taken seriously at a federal or regulatory level.The biggest limitation on CBD wasn’t consumer demand It was uncertainty—uncertainty around enforcement, regulatory ambiguity, and how cannabinoids would ultimately be governed at the federal levelThat is now changing.The recent federal executive order directing the rescheduling of cannabis from Schedule I to Schedule III is not a wellness moment. It is not a branding moment. And it is not a shortcut to mass commercialization.it is a regulatory signal.And for companies that have built CBD programs around science, safety, and regulatory rigor, it marks a meaningful inflection point .What the executive order actually changes for CBD

While CBD has been federally legal under the Farm Bill, it has lived in regulatory limbo because federal agencies largely avoided engaging with cannabinoids altogether.

Schedule III rescheduling changes the posture.

It signals federal acknowledgment of cannabinoids as a category that must be actively governed and directs agencies to engage rather than ignore. That shift matters because it removes the largest structural barrier to CBD’s evolution: the absence of a clear, coordinated federal regulatory framework.

This does not mean CBD is suddenly FDA-approved.
It does mean CBD is now being discussed and evaluated within the same institutional and regulatory context as other controlled, high-scrutiny ingredients.

That distinction is everything.

From wellness narratives to regulated industry maturity

The next phase of CBD will not be driven by lifestyle positioning or influencer marketing.

It will be driven by:

•  toxicology data
• safety margins
• impurity controls
• dose consistency
• stability and degradation behavior
• defensible specifications
• regulatory documentation that can withstand scrutiny

This executive order accelerates a transition that has been quietly underway for years: CBD moving out of the wellness aisle and into regulated, high-scrutiny product conversations.

That transition favors companies who invested early in infrastructure rather than shortcuts.

Why early regulatory investment now matters

At Mile High Labs, we did not build our CBD platform around market trends. We built it around inevitability.

Long before federal posture shifted, we invested in:

• comprehensive toxicology studies
• GMP manufacturing controls designed for regulated markets
• THC risk management systems
• data-driven specifications designed for regulated end uses
• stability and formulation work suitable for beverages and other regulated product formats
• novel foods dossiers for both the UK and EU

Those investments were not fast.
They were not inexpensive.
And they were not made for short-term wins.

They were made because we believed CBD’s future would ultimately be decided by regulators, institutions, and governed markets—not marketing teams.

The executive order reinforces that thesis.

What this means for brands, formulators, and product teams

As federal agencies re-engage with cannabinoids, the CBD market will narrow before it grows.

Not every product will survive increased scrutiny.
Not every supplier will be defensible.
And not every formulation will meet the standards required for regulated markets.

The questions being asked are already changing:

Can this ingredient withstand regulatory review?
Can I defend it to legal and quality teams?
Can it be exported into regulated international markets?
Can it be supported by safety and research data? CBD is no longer about access.
It’s about assurance.

Where Mile High Labs fits in the next phase?

We work with companies who already understand where this is heading.

Regulated and science-led brands.
Beverage innovators operating under global regulatory constraints.
Product teams building for the UK, EU, Japan, and other high-barrier markets.
Organizations that understand “good enough” is no longer good enough.

The executive order does not create these opportunities—but it validates them.

It signals that CBD’s future will be shaped by evidence, systems, and regulatory credibility.

That is the work we’ve been doing all along.

What’s next

If you are building CBD products intended for:

• regulated food and beverage markets
• high-scrutiny product categories
• international expansion
• long-term institutional adoption

Now is the time to reassess whether your ingredient strategy is built for where the category is going—not where it has been.

We’re happy to have that conversation.

Contact Mile High Labs to discuss compliant CBD ingredient solutions built for regulated markets and the next phase of cannabinoid commercialization.

Sources and References

For readers who want to review the underlying federal actions referenced in this article:

2. For readers who want to review the underlying federal actions referenced in this article:
3. Executive Order: Increasing Medical Marijuana and Cannabidiol Research Source: WhiteHouse.gov https://www.whitehouse.gov/presidential-actions/2025/12/increasing-medical-marijuana-and-cannabidiol-research/
4. White House Fact Sheet: President Donald J. Trump Is Increasing Medical Marijuana and Cannabidiol Research Source: WhiteHouse.gov
   https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-is-increasing-medical-marijuana-and-cannabidiol-research/

Dry January Isn’t Dry. It’s Directional.

What ingredient-led, CBD, and non-alcoholic beverages reveal about the future of beverage innovation.

Dry January has become a recurring moment on the calendar. For many in the beverage industry, it’s more than a seasonal shift—it’s a signal. A time when consumer curiosity about alternatives to traditional alcoholic beverages becomes visible. A moment where beverage brands reassess portfolio relevance, broaden offerings, and explore new ingredient possibilities. But what if Dry January isn’t just a “pause” in drinking? What if it’s an indicator of where beverage innovation is heading?

Beyond Alcohol: A Broader Beverage Landscape

The conversations around beverage choice have shifted. Consumers are exploring drinks that fit various lifestyles, occasions, and preferences. This has led to interest in three evolving categories:

• Non-alcoholic alternatives (beer, mocktails, botanical beverages)
• Ingredient-forward functional beverages
• CBD-infused beverages (with broad appeal, little to no THC)

Importantly, this shift isn’t anecdotal. Recent consumer research shows that more Americans plan to participate in Dry January than in previous years, with curiosity extending beyond alcohol itself and into what replaces it. CivicScience data suggests that many participants view Dry January not as abstention, but as an opportunity to explore new beverage choices and spending patterns beyond alcohol. These categories aren’t fleeting trends — they’re backed by measurable market growth and reinforced by evolving consumer behavior.

Market Momentum: Growth You Can See

Here’s what recent industry data shows:

 CBD-Infused Beverages Are Growing

The global CBD-infused beverages market was valued at approximately $1.45 billion in 2024and is projected to reach about $7.65 billion by 2033, reflecting sustained interest in ingredient-led, alcohol-adjacent beverage formats.
(IMARC Group)

 Non-Alcoholic Beverages Continue Expanding

The non-alcoholic beverages market — including NA beer, mocktails, and other alternatives — is on pace to grow from roughly $1.35 trillion in 2023 to around $2.1 trillion by 2033, representing continued demand for diversified beverage choices. Within that space, non-alcoholic beer has emerged as a particularly strong category. According to the Brewers Association, non-alcoholic beer is no longer a niche offering — it’s increasingly viewed as a permanent and complementary part of brewery portfolios, with many producers expanding NA lines in response to consistent consumer demand. Together, these data points reinforce a clear takeaway: non-alcoholic and alternative beverages are not seasonal experiments — they’re becoming foundational categories.

What These Trends Mean for Beverage Brands

Dry January highlights a pattern we’ve seen increasingly, consumers aren’t just opting out of alcohol for a month. They’re experimenting with beverage choice — whether for wellness, lifestyle alignment, flavor exploration, or social occasions that don’t center around alcohol. Industry coverage supports this shift. BevNET reports that functional and ingredient-forward beverages are increasingly replacing alcohol during Dry January, as consumers seek drinks that offer flavor, experience, and alignment with personal goals — without positioning alcohol as the default.

For brands and manufacturers, that matters for several reasons:

1. Expanded Portfolio Opportunities – Consumers increasingly expect choice, whether that’s a non-alcoholic alternative alongside core products or a CBD-infused beveragethat offers a different experience. This expectation creates room for innovation, not just substitution.
2. Ingredient Strategy Becomes Competitive Advantage – Formulating beverages that deliver consistent flavor, stability, and sensory appeal — whether alcohol-free or infused with actives like CBD — requires thoughtful ingredient strategy, scalable solutions, and expertise in performance across formats. Forward-looking brands recognize that ingredient quality and versatility matter as much as the final drink.
3. Choice That Feels Intentional, Year-Round – While Dry January brings attention to alternatives once a year, many consumers continue to explore non-alcoholic and ingredient-led beverages long after January ends. These aren’t just seasonal interests; they’re shifts in consumption patterns that align with broader lifestyle choices.

More Than a Moment — A Signal for Innovation

Dry January isn’t just about what people don’t drink. It’s about what they do choose. A beverage portfolio that includes thoughtful non-alcoholic options signals inclusivity and relevance. CBD-infused and ingredient-forward beverages demonstrate responsiveness to evolving consumer curiosity. Ingredient manufacturers and beverage developers who understand these shifts can help brands create products that meet consumers where they are — in both lifestyle and occasion. This moment offers insight, not interruption.

looking ahead

Dry January may be a brief window on the calendar, but the trends it reveals have staying power. For brands and beverage manufacturers, now is the time to ask:

• Does your portfolio offer choice that resonates with evolving consumer expectations?
• Are your formulations built to perform across categories?
• How can ingredient strategy support growth beyond a single season?

Consumers aren’t just reevaluating what they drink — they’re expanding what they’ll choose and that expansion is where opportunity begins.

Powering Progress: Mile High Labs at Japan’s International Hemp Expo 2025

• November 11, 2025
• Japanese CBD Industry News

At At Mile High Labs, our strength comes from the people who bring innovation, expertise, and integrity to everything we do.

This week, we’re shining a light on Monika Cehic Lucic, Senior Business Development Manager, International Sales — one of the key people driving compliant, science-backed cannabinoid innovation across global markets.

As Mile High Labs returns to Japan’s International Hemp Expo (JIHE 2025) — one of the largest hemp and cannabinoid industry events in Japan’s history — we’re proud to stand alongside more than 120 exhibitors dedicated to advancing the conversation around quality, compliance, and the responsible future of cannabinoids.

A Global Perspective, A Local Commitment

What excites you most about returning to Japan for the Hemp Expo?

I’m really excited to see how quickly the CBD and wellness industries in Japan are evolving. There’s a strong focus on safety, transparency, and quality — values that perfectly align with what we do at Mile High Labs. I’m looking forward to reconnecting with partners, showcasing our Japan-compliant cannabinoid ingredients, and supporting the responsible growth of this vibrant and dynamic market.”

From our early commitment to compliance to our continued investment in science and quality systems, Mile High Labs is uniquely positioned to help brands thrive as Japan’s cannabinoid framework continues to evolve.

Built for the World’s Most Regulated Markets

Mile High Labs’ 2.0 ingredient line represents the next generation of cannabinoid manufacturing — engineered for precision, validated for compliance, and trusted worldwide.

Our ingredients are designed to meet the strictest global standards, including those set forth by the Japan Ministry of Health, Labor and Welfare (MHLW), the UK FSA, and the EU EFSA. Every ingredient undergoes full toxicology review, ISO 17025-accredited third-party testing, and NSF GMP manufacturing validation to ensure safety, consistency, and transparency at every stage. We’ve got you covered.

Featured at JIHE 2025:

• CBD Isolate 2.0 — Japan- and UK-compliant; Δ9-THC and CBN below detectable limits.
• CBG Isolate 2.0 — ≥ 98% purity, designed for regulated markets with full compliance data.
• 20% CBD Isolate 2.0 Water Soluble Liquid — our most advanced formulation, offering stability, rapid dispersion, and exceptional compliance for functional beverage applications.

These products are a reflection of our core principles: Compliance. Quality. Safety. Built into every ingredient.

The Evolving Conversation Around CBN

While CBN will be part of the broader dialogue at JIHE 2025 — including new discussions on self-regulation and industry transparency — Mile High Labs continues to monitor developments closely, prioritizing responsible participation and accurate information as Japan refines its approach to cannabinoid policy.

Our focus remains on supporting the market with fully compliant CBD and CBG ingredientsbacked by scientific validation, helping partners navigate these shifts with confidence and clarity.

Powering Progress, Together

What does ‘Powering Progress’ mean to you?

“To me, Powering Progress means driving meaningful change and growth. As we expand into new markets like Japan, it’s about building trust through compliance, education, and partnership. True progress comes from listening to local needs, adapting responsibly, and delivering innovative, high-quality products that raise the bar. Every conversation, collaboration, and new relationship helps move the industry forward.”

As Japan’s market continues to mature, we’re proud to contribute to a movement defined by science, safety, and shared progress — one that connects innovation with integrity.

Inspired by Collaboration

What’s your favorite part of visiting Japan? What stands out most about Japan is how seamlessly it blends respect for tradition with a drive for innovation. The country’s dedication to excellence and attention to detail reflects our own commitment to quality at MHL. I’m always inspired by the hospitality, the incredible food, and the thoughtful conversations with partners who share our passion for doing things the right way.

At Mile High Labs, collaboration is at the heart of everything we do — and Japan continues to be a model for how innovation and responsibility can grow hand in hand.

Mile High Labs is the global leader in cannabinoid ingredient manufacturing — trusted by the world’s leading brands for compliant, science-backed CBD and cannabinoid solutions.

Compliance. Quality. Safety.
Built into every ingredient.

UK CBD Compliance Made Simple by Mile High Labs

We’ve Got You CovereD

The CBD landscape in the UK just changed — but if you’re working with Mile High Labs, your brand is already ahead.

In July 2025, the Food Standards Agency (FSA) rolled out critical updates to its CBD business guidance — including a provisional Acceptable Daily Intake (ADI) of 10 mg CBD/day, a Safe Upper Limit of 0.07 mg THC/day, and new permissions for companies to reformulate and update products listed on the CBD Public List. For brands and manufacturers scrambling to keep pace, the pressure is on. But at Mile High Labs, we built for this moment years ago.

 We’ve got you covered.

What’s Changing in UK CBD Regulation?

According to the FSA’s official CBD guidance, products on the UK market must now align with:

• 10 mg/day CBD intake for healthy adults
• 0.07 mg/day THC (1 µg/kg bodyweight/day)
• Ongoing 1 mg THC per container limit (per Home Office rule)

And if your products are on the CBD Public List, you’re expected to reformulate for safety, update labels with consumer warnings, and prepare for the first wave of official product authorisations.

For many companies, this means reformulation chaos.

For Mile High Labs, it’s just another proof point that we were built for regulated markets.

Why Mile High Labs Leads — And Why That Matters to You

We didn’t wait for regulators to set the bar.
We raised it ourselves.

• CBD Isolate 2.0: Launched in 2022, engineered to eliminate all detectable THC variants (Δ9-THC, Δ8-THC, THCA) — not in response to enforcement, but in anticipation of it.
• Published FSA Safety Assessment: Among the highest ADI ratings across Group A applicants.
• 12 Fully Validated End-Use Categories: Including chewing gum, chocolate products, confectionery, flavoured drinks, fruit juices, honey, CBD-infused water, capsules, tablets, liquids, syrups, and chewable forms — more end-use categories than any other company currently on the Public List, where competitors typically offer only 1–3.
• Direct Manufacturing Control: We own our supply chain, control our production, and deliver zero disruption for partners.

While others share regulatory risk, we eliminate it — giving your brand peace of mind, resilience, and a decisive competitive edge.

Reformulation? Relabeling? Innovation? With Mile High Labs, You’re Already Compliant — And Ready to Lead

With the FSA now permitting limited reformulation and supplier changes for products on the CBD Public List, many brands are wondering:

• Do we need to reformulate?
• Can we meet the new ADI + THC limits?
• Will we have to pull products or update labels?

If you’re with Mile High Labs, the answer is simple You’re already aligned.
 You’re already supported.
 You’re already protected.

Why Now Is the Time to Innovate

Now isn’t just the time to react — it’s the time to innovate.

 Start R&D and formulation work .Expand your product portfolio and SKUs. Prepare stability and market testing.
 Get ready to be first to shelf when authorisation arrives.

Mile High Labs is your one-stop partner to move from compliance to category leadership.

 Leading the Way, Together

We believe regulatory alignment isn’t just a checkbox — it’s a commitment to consumer safety, product integrity, and long-term brand success.

As the industry moves toward stronger compliance and collaboration, Mile High Labs stands out as the only CBD partner offering compliant ingredients across 12 validated end-use categories — unmatched by any other supplier on the Public List.

Don’t just keep up. Lead the market.

Discover how our CBD Isolate 2.0 andWater-Soluble CBD solutions are already built for success.

 Ready to Future-Proof Your Brand?

The CBD market is evolving fast. With Mile High Labs, you’re not just surviving the shift — you’re thriving in it.

Turnkey compliance across 12 validated end-use categories . Published safety dossier + top-tier regulatory status. Global manufacturing excellence . Unmatched technical and customer support

Talk to our sales team today to lock in your compliant ingredient supply before competitors do.

 Don’t Wait — Get Ahead Before Authorisations Roll Out

We’re helping partners across the UK, EU, and Japan secure regulatory-ready products now— before the next wave of authorisations changes the market.

Avoid reformulation chaos . Protect your shelf space .Accelerate your go-to-market plans.

Learn more and explore the full CBD Public List here: CBD Public Understand the latest FSA updates here: FSA CBD Business See how industry leaders are shaping the future: Cannabis Trades Association Article

---

20% CBD Isolate 2.0 Water Soluble Liquid
Mile High Labs Solves Major Beverage-Focused Compliance and Supply Chain Issues with the Launch of WS 2.0

Tired of Regulatory Red Tape and Inconsistent Supply Chains? WS 2.0: 20% CBD Isolate 2.0 Water Soluble Liquid Solves Both. Global-Ready. Supply Chain-Safe. Formulation-Proven. 

The global functional beverage market is booming — but so are the regulatory roadblocks. Brands looking to scale internationally need more than just a potent ingredient. They need an innovation partner who understands what it takes to get across the finish line. That’s why Mile High Labs developed WS 2.0 – 20% CBD Isolate 2.0 Water Soluble Liquid. This isn’t another emulsion. It’s a precision-engineered ingredient designed to clear the world’s toughest compliance hurdles while keeping your formulation effortless, stable, and scalable.

Why Now?

Beverages are winning the shelf. Consumers are walking away from sugar-heavy energy drinks and alcohol and reaching for functional drinks that support recovery, focus, and stress relief. At the same time, markets like Japan, the UK, and emerging APAC countries are tightening regulations and demanding documentation: toxicology data, verified THC limits, and full transparency on ingredient sourcing. WS 2.0 meets the moment — with real data, not empty claims. If you’re targeting Japan, the UK, or any market with ultra-tight THC thresholds, WS 2.0 is built to deliver:

• ≤ 0.00001% (≤ 0.1 ppm)  THC, THCA, THCV, Δ8/Δ9, and CBN — compliant with Japan’s Narcotics Control Law and the UK’s Novel Foods framework, supported by toxicology studies on Mile High Labs-manufactured CBD Isolate
• Micro-emulsified at 200mg/mL — seamless dispersion with minimal volume
• ISO 17025-verified + NSF GMP-manufactured — real compliance, not just claims
• One 100mL bottle = 1,000 servings at 20mg CBD

Strategic Shift: Innovating How CBD Enters Regulated Markets

The industry norm? Launch high-cost tinctures and gummies first — then trickle into beverages later. We’re flipping that model.

WS 2.0 Reflects a Deliberate Shift: Beverages are lower-cost, faster-moving, impulse-friendly, and ideal for market testing and consumer education. We’re helping our partners lead with formulations that break through — not just comply. We’re not turning our backs on traditional finished goods — they still have a role. But beverage-forward innovation gives brands a faster path to scale, with less friction and more upside. That’s what Innovation Leadership in Action: Pioneering What’s Possible looks like.

Product Snapshot: WS 2.0 – 20% CBD Isolate 2.0 Water Soluble Liquid

This is formulation freedom in a bottle. WS 2.0 is a high-potency, crystal-clear, micro-emulsified concentrate manufactured in our NSF cGMP-certified facility in Colorado. It blends seamlessly into beverages, functional shots, and wellness formulas.

Key Specs:

• 200mg/mL of CBD — ultra-potent and efficient
• ≤ 0.00001% (≤ 0.1 ppm)  THC, THCA, THCV, Δ8/Δ9, and CBN
• ISO 17025-tested + CDPHE-verified
• pH-stable, shelf-stable, and virtually tasteless

Dosing Efficiency:

• 25mg per can? Just 0.125mL
• 30mg per shot? Only 0.15mL
• One 100mL bottle = up to 1,000 units

Designed for the Most Stringent Markets

Regulators are raising the bar. We’re already above it. WS 2.0 complies with:

• Japan’s Narcotics Control Law
• UK’s Novel Foods framework, including safety and toxicology studies validated on our CBD Isolate

≤ 0.00001% (≤ 0.1 ppm) THC is not a goal — it’s a guarantee. And achieving that in a 20% aqueous product doesn’t happen by chance.

MHL has the expertise and partnerships to ensure compliance regardless of specification. We’ve done the work. We’ve run the data. And we’ve built the system that gets you where you need to go — without the fear of failing a test or being held at the border.

No Middlemen. Total Visibility. Manufacturer-Owned Process.

We don’t just supply ingredients — we manufacture them ourselves.

With WS 2.0, you get:

• Direct access to our Quality, Regulatory, Supply Chain, R&D, and Sales teams
• Transparent, traceable documentation from raw isolate to finished liquid
• Batch-level data and declarations, including:
  • COAs
  • NSF cGMP certification
  • Microbial, elemental, pesticide, and residual solvent test results
  • Stability data
  • Comprehensive regulatory declarations (including allergen, GMO, microbial, heavy metals, residual solvents, food-grade status, and more)

Everything you Need to Pass Inspection, Enter Markets, and Move Fast

Request Your Free 15mL Formulation Sample

WS 2.0 is available now to formulation teams, regulatory leads, and brand innovators ready to go global. To support your launch strategy, Mile High Labs is offering a limited number of free 15mL R&D trial samples of WS 2.0. Whether you’re building your flagship beverage or testing market entry in Japan, this is your regulatory foundation — and your competitive edge.

Let’s eliminate the barriers — and unlock your next market.

Mile High Labs

The Future of CBD

What the UK’s Novel Foods Milestone Means for the Future of CBD: A Call for US Regulatory Change

This is more than just a regulatory checkbox—it’s a critical step towards establishing a safer, more reliable global CBD marketplace. While the UK is taking strides to regulate its market, the US lags behind, leaving many to wonder: What’s next for CBD regulation in the US? There is a growing call for US regulatory change to address this lag.

Let’s explore what this milestone means for global trade, consumer safety, and why the US should be paying attention.

What is the UK’s Novel Foods Process and Why Does it Matter?

The UK’s Novel Foods regulation requires detailed safety assessments for any products not commonly consumed before May 1997. For CBD manufacturers, it’s a rigorous but necessary process to ensure that products meet safety standards before they’re available on the market.

At Mile High Labs, achieving this milestone is a validation of our commitment to quality and regulatory compliance. But it’s also a message to the global CBD market: We’re ready for what’s next.

What’s Happening in the US? 

Unlike the UK, the US currently operates in a regulatory gray area when it comes to CBD. The lack of federal oversight creates inconsistent standards and risks for consumers.  

Some key differences between the US and UK markets include: 

• Safety Requirements: The UK mandates detailed safety testing, while the US varies by state, leading to gaps in product quality. 
• Consistency Across Regions: The UK’s uniform standards create predictable outcomes for manufacturers. In contrast, US companies face a patchwork of local regulations. 
• Consumer Confidence: UK consumers can trust that approved products have been thoroughly vetted. In the US, uncertainty remains. 

What can the US learn from the UK’s approach?

If the US wants to protect consumers and expand its global footprint, it needs a similar commitment to regulation. 

Global Trade: Why Regulation Matters

Regulation isn’t just about consumer safety—it’s a competitive advantage in the global marketplace. Companies like Mile High Labs that meet international standards are already positioned to export globally, opening opportunities in markets with strict requirements like Japan, the EU, and now the UK. 

The Role of US Companies in Global CBD Export

Mile High Labs has been a pioneer in navigating global certifications and regulatory approvals. Our experience highlights how companies like MHL can lead the charge if they embrace international standards. With the USA being the founders of this industry, we should be leading the drive for global regulation and compliance. But here’s the catch: Without a robust regulatory framework in the US, many companies could be left behind. As global markets tighten their standards, those that don’t comply risk losing access to key regions.

The Big Question: Will the US Follow Suit?

The UK has proven that regulated CBD markets are possible. Could the US be next? Or will it continue to miss out on the benefits of a safer, globally competitive industry? 

Why Should You Care?

This isn’t just about policy—it’s about the future of the CBD industry. If the US doesn’t step up, companies could face: 

• Limited export opportunities 
• Inconsistent product quality and safety risks 
• A growing gap between international standards and domestic production 

Do we really want to be left behind while other countries move forward? 

Gloves Off: What Comes Next 

It’s time for the US to take regulation seriously. The UK has shown that when companies play by the rules, everyone wins—consumers, manufacturers, and regulators alike. So, why not here? 

Let’s drive the conversation forward. Regulation isn’t a hurdle—it’s an opportunity. With leadership and commitment, the US CBD market can thrive on a global scale. 

Want to learn more about how Mile High Labs is setting the standard in CBD regulation and global export? Contact us today.

Let’s Shape the Future—Together

Mile High Labs is the clear choice for UK Novel Foods Success. Stay tuned for more—or reach out not to kick-start your UK Expansion

Mile High Labs Achieves Milestone in UK Novel Foods Process

Read More

Mile High Labs Cements its Place in the Regulatory CBD Space. First Hemp-Derived CBD Ingredient Manufacturer to Enter Risk Management Phase.

LONDON, Jan. 31, 2025 /PRNewswire/ — Mile High Labs (MHL), a global leader in hemp-derived cannabinoid ingredients and finished products, is proud to announce its progression to the Risk Management Phase of the UK Novel Foods process. This milestone establishes MHL as the first and only hemp-derived CBD manufacturer to reach this advanced stage of regulatory approval, reinforcing its commitment to compliance, quality, and innovation.

In early 2019, Mile High Labs was one of the first manufacturers in the CBD industry to receive GMP and ISO 9001 certifications. The Company’s testing methodologies have been adopted by premier testing labs worldwide and have earned Mile High Labs five Emerald badges for excellence. This achievement builds upon five years of expertise in developing robust in-house data and refining proprietary processes—an effort unmatched by many competitors who depend on external or synthetic sources.

When the FSA announced that CBD would be classified as a novel food ingredient, Mile High Labs prepared a dossier that contained manufacturing data, product specifications, stability data, quality control methodologies, and toxicological data to support the safe consumption of CBD. Unlike others relying on consortium data, Mile High Labs conducted its own detailed studies, ensuring a solid foundation of evidence for regulatory success.

“The compliance and integrity of our customers’ products will always be our top priority,” said Gary Korb, Director of Quality, Mile High Labs. “Brands concerned about the current and future legal status of their products are already working with us, and we urge those who are not quite ready for this new era of regulation to reach out to us for support. We’re here to help.”

This regulatory advancement moves Mile High Labs one step closer to authorization, which, on completion provides significant opportunities for food manufacturers. More than just food supplements, Mile High Labs supports a wide range of products, including beverages, confectionery, honey, chocolate. etc. Mile High Labs’ data backs up an expansive category list; the broadest in the industry. This ensures that our partners can expand their brand portfolio while maintaining consistent quality, allowing manufacturers to explore innovative formulations that meet the increasing demand for CBD products in mainstream markets.

“Achieving this milestone is a testament to our rigorous compliance efforts and dedication to setting the global standard for CBD manufacturing,” said John Wallace, Chief Commercial Officer, Mile High Labs. “We are excited to expand formulation options for UK food manufacturers, paving the way for CBD to become an integral part of everyday consumer products.”

Mile High Labs’ comprehensive ingredient portfolio is backed by industry-leading safety data. Mile High Labs delivers end-to-end expertise, ensuring customers gain a competitive edge in the evolving CBD market.

Mile High Labs’ commitment to compliance extends beyond the UK, with its ingredients and finished goods meeting strict regulatory standards across other global markets. The company’s forward-thinking approach ensures customers can confidently bring compliant, high-quality CBD products to the market.

As the UK market for CBD continues to evolve, Mile High Labs remains at the forefront, providing tailored solutions for food manufacturers eager to meet consumer demand in this emerging sector. Over the next year, Mile High Labs will introduce new product categories, innovative formulations, and collaborative opportunities to shape the future of CBD-infused food products in the UK.

“Partnering with Mile High Labs is about more than just sourcing an ingredient.” Added John Wallace, “You’re gaining access to a team of experts, proprietary data, and scalable solutions.”

Let’s Shape the Future—Together

Mile High Labs is the clear choice for UK Novel Foods Success. Stay tuned for more—or reach out not to kick-start your UK Expansion.

CBC Water Soluble Liquid

Revolutionizing Functional Beverages with Mile High Labs’ CBC Water Soluble Liquid

After countless hours in the lab, intensive testing, and collaboration with some of the brightest minds in the industry, we’re proud to introduce our newly formulated 20% CBC Water Soluble Liquid. Mile High Labs is redefining the cannabinoid-infused product market with our CBC Water Soluble Liquid. This advanced micro-emulsion liquid concentrate is the first of its kind, containing 20% CBC Isolate in a convenient, water-soluble form. Designed for seamless integration into beverages, it offers unmatched stability and consistency, making it a breakthrough choice for formulators in the functional beverage market.

Why does this matter? Because we know that behind every groundbreaking product is a need for reliability, consistency, and a formulation partner who understands what it means to push boundaries. This new ingredient isn’t just another addition to the market—it’s a demonstration of what can happen when innovation leads the way.

Unique Nature of CBC and Why There Are Currently No CBC Water Soluble Liquids on The Market

Cannabichromene (CBC) is a non-intoxicating cannabinoid found in cannabis, offering distinct benefits without the psychoactive effects of THC. Despite its potential, CBC has often been overshadowed by more widely recognized cannabinoids like CBD or CBG. Its unique interaction with TRPV1 and TRPA1 receptors, which play a role in various physiological processes, highlights its promise in wellness applications.

However, the development of water-soluble CBC liquids has been a challenge due to the technical complexities involved in making cannabinoids compatible with water-based systems. At Mile High Labs, our proprietary micro-emulsion process has made it possible to overcome these hurdles, paving the way for innovative CBC-infused beverages and other functional products. This breakthrough positions our CBC Water Soluble Liquid as a first-of-its-kind solution in the cannabinoid market. This innovation provides brands with a clean, reliable, and scalable solution to bring CBC cannabinoid products to market.

Key Benefits of Mile High Labs’ CBC Water Soluble Liquid:

1. Stable & Reliable: With up to an initial 12 months of stability at room temperature, our CBC Water Soluble Liquid is built to last. We are also continuing our stability studies, so stay tuned for more updates as we progress.
2. High Potency: Each 100ml formulation bottle has 20,000 mg of CBC, enough for up to 1,000 cans—ideal for soft launch or market testing. We also have our standard sizes for your convenience.
3. Balanced Blends: When paired with our staple cannabinoids such as CBD, CBN, and or CBG; CBC integrates into your beverage without altering its flavor, contributing to a unique, functional profile.

---

---

The Non-Alcoholic Beverage Revolution

The non-alcoholic beverage industry is booming as consumers shift toward mindful drinking. Increasingly, people are seeking drinks that not only taste great but also enhance their wellness routines. Functional beverages, infused with cannabinoids like CBC, adaptogens, and nutrients, are leading this transformation by providing benefits beyond hydration. According to Leafly, CBC’s interaction with TRPV1 receptors suggests its potential in soothing discomfort and supporting wellness goals. This makes it particularly attractive to younger demographics looking for sophisticated, non-alcoholic alternatives that align with their active lifestyles.

Functional drinks infused with cannabinoids are bridging the gap between wellness and indulgence. While CBD dominates this space, CBC is emerging as a key ingredient due to its distinctive properties. As High Times Magazine notes, CBC may offer benefits related to mood regulation and overall balance within the body. By offering CBC-infused beverages, brands can stand out in a competitive market, delivering a unique and sought-after experience to consumers.

Why Now is the Time to Innovate with CBC

The current demand for non-alcoholic functional beverages presents a golden opportunity for brands to incorporate CBC. Unlike alcohol, CBC allows consumers a new option without intoxication, appealing to wellness-focused individuals. Mile High Labs’ CBC Water Soluble Liquid provides an easy way to capitalize on this trend, delivering a premium ingredient that enhances product appeal.

Trusted Resources for Beverage Innovators

Recommended Resources for Beverage Formulators: To support your product development journey, here are valuable resources that offer insights into beverage trends, packaging solutions, labeling, and canning—essentials for bringing a successful product to market.

• BevNET – A trusted source for industry news, product launches, and insights into trends across non-alcoholic and functional beverages, BevNET provides up-to-date information and expert commentary on what’s shaping the beverage industry. Visit BevNET
• Nosh – Focused on natural, organic, and wellness-oriented products, Nosh explores consumer demands and market dynamics in the functional beverage space, helping you stay attuned to shifts in wellness trends. Visit Nosh
• The Die Line – This leading site in packaging design and branding showcases innovative, visually compelling packaging. From inspiring design concepts to emerging packaging technologies, The Die Line offers inspiration to ensure your product stands out on the shelf. Visit The Die Line
• Leapin Lizard Labels – Specializing in custom labels, Leapin Lizard Labels supports brands with high-quality, durable labeling solutions. This resource helps ensure your product’s packaging meets branding standards while being equipped for real-world handling. Visit Leapin Lizard Labels
• Full Metal Canning – Full Metal Canning provides premium canning solutions for beverage brands, with a focus on quality, flexibility, and support. Their services are ideal for scaling up production while maintaining quality, which is essential for entering competitive markets. Visit Full Metal Canning

These resources keep you informed on industry trends, packaging, labeling, and canning solutions, empowering you to create standout CBC water-soluble cannabinoid formulations that resonate in the functional beverage market.

Functional Beverages and Cannabinoids: A Perfect Pair

With the popularity of functional drinks on the rise, cannabinoids like CBD and CBC have emerged as key ingredients in the non-alcoholic beverage space. These cannabinoids offer unique, non-intoxicating effects that align with consumer interests. Cannabichromene (CBC)is gaining attention for its potential benefits related to the endocannabinoid system, providing an option for consumers seeking a mindful and balanced approach to health. Unlike CBD, CBC interacts with TRPV1 and TRPA1 receptors, opening up new avenues for product differentiation in functional beverages. By formulating CBC-infused beverages, brands can capture the interest of consumers looking for alternatives without alcohol.

---

---

Why Mile High Labs?

Mile High Labs is committed to advancing the cannabinoid industry through rigorous product development, quality assurance, and consumer-focused solutions. With over 50 million units of finished beverages formulated annually, we have the expertise to support your brand’s goals in creating reliable and innovative products. At Mile High Labs, we’ve always believed that innovation happens at the intersection of expertise, passion, and a relentless drive to redefine what’s possible. That’s why we’re excited to share another milestone that we are incredibly proud of. 

Why partner with us? As you plan for the rest of 2024 and into 2025, partnering with Mile High Labs positions your brand to lead in the functional beverage market. Our expertise in water soluble technologies ensures you stay ahead with innovative, high-quality products. With an industry-first concentration, we’re setting a new standard that enables product developers to explore previously unattainable possibilities.

For us, it’s not just about creating products. It’s about creating a platform for our partners to elevate their own formulations and achieve something exceptional. Because at the end of the day, it’s your vision we’re here to bring to life.

Request a Sample and Innovate with CBC Water Soluble Liquid

Ready to experience the possibilities of CBC cannabinoid products? Our CBC Water Soluble Liquid is ready for formulation, offering unparalleled ease and quality. We invite you to explore this product and unlock the potential of CBC Isolate in your beverage line. Request a sample today to discover why CBC Water Soluble Liquid could be the next big thing in your product innovation journey!

From Molecule to Market—Stay in the Know

Subscribe for updates on cutting-edge cannabinoids, new launches, and expert insights.

Cutting Through the Noise

Why Japan’s CBD Market Demands Direct, Compliant Partnerships

Tokyo, Japan – 1 April 2025 – As Japan cautiously begins to open its regulatory doors to CBD, the opportunity for growth is undeniable—but so is the risk. Rapid industry expansion often attracts opportunists: brokers and resellers who prioritize paperwork over product, and sales over safety. For Japanese businesses and consumers alike, this emerging landscape requires more than ambition—it demands accountability.

At Mile High Labs, we’ve seen firsthand how supply chains can break down when companies rely on middlemen. That’s why we’ve built our entire business around direct partnerships, regulatory precision, and full vertical integration—from raw material to finished product. As one of the few cannabinoid manufacturers poised to support the Japanese market, we’re ready to meet the moment with credibility, consistency, and compliance.

Japan’s CBD Market: Opportunity Meets Obligation

Japan’s regulatory environment is among the most rigorous in the world. With strict controls over THC content and sourcing, the path to compliant cannabinoid products has been narrow—until recently. Updates to the country’s Pharmaceutical and Narcotics Control Laws signal a shift in opportunity, but that shift comes with high expectations.

Japanese businesses entering the CBD space must be prepared to meet criteria including:

• Controlled Cannabinoid Compliance
• Traceability from Plant to Product
• Third-Party Testing & Transparency
• Compliance with International GMP Standards

This is not the market for shortcuts. And it’s certainly not the time to trust unknown intermediaries who can’t validate their supply chain or answer basic regulatory questions.

The Risks of Middlemen

The reality is many “suppliers” in this industry are not manufacturers—they’re brokers. These middlemen often resell CBD produced by someone else and rely solely on a certificate of analysis (CoA) to legitimize their offering. But in highly regulated markets like Japan, a CoA alone isn’t enough.

Brokers:

• Can’t ensure consistent quality
• Don’t have technical or regulatory expertise
• Add unnecessary costs and delays
• Disappear when things go wrong

And perhaps most importantly, they don’t manufacture anything.

Direct from the Source: The Mile High Labs Advantage

At Mile High Labs, we manufacture our cannabinoids in our NSF GMP 21 CFR 11 and 21CFR 117-compliant facility located in Colorado. All testing is performed by MHL approved 3^rd party labs that are ISO 17025 and CDPHE Certified.

That level of accountability means:

• Full traceability and documentation
• In-house quality control and regulatory teams
• Consistent inventory and technical support
• Regulatory expertise with global scope

MHL has commissioned safety and toxicological studies completed by an independent SRO (Scientific Research Organization) and verified by government agency to demonstrate safety for use in multiple categories like Food Supplement, Beverage, Gummies, Capsules, Oils etc. We demonstrate our responsibility and commitment to quality and safety to brands and consumers.

We’ve invested in building one of the most advanced cannabinoid production platforms in the world—because that’s what international markets like Japan require.

Backed by Global Compliance

Our commitment to regulatory excellence isn’t new—it’s foundational. We recently achieved a key milestone in the UK’s Novel Foods process, where we became one of the first global CBD manufacturers to have a validated application linked to a named product and brand  Read the full announcement about our UK Novel Foods progress

This kind of regulatory achievement isn’t just about market access—it’s about demonstrating trust, transparency, and long-term readiness in regions that, like Japan, demand a higher standard.

Spotlight Product: CBD Isolate 2.0

Our CBD Isolate 2.0 is a perfect example of our regulatory-first approach. Developed to meet the strictest international guidelines, including markets like Japan, CBD Isolate 2.0 is:

• Consistently non-detect THC
• Ultra-pure, hemp-derived CBD (≥ 99%)
• Backed by a complete technical and regulatory dossier
• Designed for global compliance and versatile formulation

This isn’t just a refined ingredient—it’s a forward-thinking solution built for regulated markets from day one.

Why It Matters for Japan

What does this mean for your business in Japan?

It means you can:

• Avoid costly delays and compliance issues
• Rely on consistent, fully traceable supply
• Work directly with a manufacturer, not a middleman
• Access pallet-ready inventory and customized support
• Tap into a global team with regional insight and regulatory fluency

We’re not just another name with a CoA—we’re a strategic partner ready to help you navigate the evolving regulatory environment with confidence.

Moving Forward Together

As Japan’s CBD market matures, the brands that succeed will be those who prioritize quality, trust, and regulatory precision. At Mile High Labs, we’re proud to offer all three.

If you’re looking for a partner who understands the landscape—and has the infrastructure to support your success—skip the middleman and work directly with the manufactur

From Molecule to Market—Stay in the Known

All scientific data and research presented on this page are sourced from Mile High Labs and are used with permission for educational and commercial purposes.
North Star CBD operates as the official exclusive distributor in the Middle East, Caucasus, and Central Asia.

Request Bulk Pricing & COA

Please complete the form below to receive wholesale pricing, technical specifications, and Certificate of Analysis (COA) for our products.

✔ Pharmaceutical, Cosmetic & Functional Beverage Applications
✔ Third-Party Tested with Verified COA
✔ Reliable Bulk Supply for Global B2B Clients
✔ Fast Response Within 24 Hours